Open AccessMedicine

Sarah B Whittle, Valeria R Smith, E. Doherty, Sibo Zhao, S. McCarty, P. Zage

2017.3.15Expert Review of Anticancer Therapy

DOI: 10.1080/14737140.2017.1285230

tlooto Summary

The identification of newer tumor targets and of novel cell-mediated immunotherapy agents may lead to novel therapeutic approaches, and clinical trials for regimens designed to target individual genetic aberrations in tumors are underway.

Abstract

Abstract is not available.

Citation format

WHITTLE, Sarah B, et al. Overview and recent advances in the treatment of neuroblastoma. Expert Review of Anticancer Therapy, 2017, 17: 369–386.